In a nutshell This study aimed to investigate the effects of chemotherapy alone or chemotherapy plus anti-PD1 therapy in patients with relapsing/refractory (RR) Hodgkin's Lymphoma. The main finding was that anti-PD1 treatment enhances the effectiveness of chemotherapy in these patients. Some background Stem cell transplant (SCT) and...
Read MoreType(s) of chemotherapy-DHAP Posts on Medivizor
Does biosimilar filgrastim improve neutropenia in older DLBCL patients receiving chemotherapy?
In a nutshell This study analyzed the outcomes of older patients with stage 3 or 4 DLBCL (diffuse large B-cell lymphoma) who received biosimilar filgrastim (Neupogen) during their chemotherapy. The study concluded that filgrastim was safe and effective in these patients. Some background Diffuse large B-cell lymphoma (DLBCL) is the most common type...
Read MoreCarboplatin as a replacement for cisplatin in DHAP chemotherapy for Hodgkin lymphoma
In a nutshell The authors investigated the use of carboplatin instead of cisplatin in the DHAP chemotherapy regimen. The authors concluded that carboplatin is less toxic that cisplatin, and may be a good substitute. Some background Hodgkin lymphoma (HL) is generally considered a curable disease. However, some patients do not respond to first...
Read More
